|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-8-15
|
|
pubmed:abstractText |
To determine if the prevalence of 2 prothrombotic genetic factors, factor V Leiden and prothrombin gene mutation, is increased in patients with antiphospholipid (aPL) antibodies with a history of venous/arterial thrombosis compared to patients with aPL antibodies with no history of thrombosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1683-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12180730-Adult,
pubmed-meshheading:12180730-Aged,
pubmed-meshheading:12180730-Aged, 80 and over,
pubmed-meshheading:12180730-Antibodies, Antiphospholipid,
pubmed-meshheading:12180730-Antiphospholipid Syndrome,
pubmed-meshheading:12180730-DNA Mutational Analysis,
pubmed-meshheading:12180730-Factor V,
pubmed-meshheading:12180730-Female,
pubmed-meshheading:12180730-Humans,
pubmed-meshheading:12180730-Male,
pubmed-meshheading:12180730-Middle Aged,
pubmed-meshheading:12180730-Point Mutation,
pubmed-meshheading:12180730-Polymerase Chain Reaction,
pubmed-meshheading:12180730-Prothrombin,
pubmed-meshheading:12180730-Risk Factors,
pubmed-meshheading:12180730-Thrombosis
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
|
|
pubmed:affiliation |
Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
